DNA topoisomerases as anticancer drug targets.
Schneider
E
E
Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Hsiang
Y H
YH
Liu
L F
LF
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D004264:DNA Topoisomerases, Type I / Q000502:physiology; D004351:Drug Resistance; D006801:Humans; D059004:Topoisomerase I Inhibitors
D000970:Antineoplastic Agents; D059004:Topoisomerase I Inhibitors; D004264:DNA Topoisomerases, Type I